(Q90925123)
Statements
Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status (English)
Hanne Kanstrup
Karina Dahl Steffensen
scientific article published on 27 September 2017